Now Open: Virginia Catalyst Special COVID-19 Grant Round
RICHMOND, VA – January 28, 2021 – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is conducting a formalized, competitive, one-time COVID-19 Therapeutic Drug Grant Funding Round of up to $5,000,000 to:
The Catalyst is now accepting applications for this special COVID-19 Grant Round.
Learn more about the Funding Criteria for COVID-19 Grant Round
Read the full press release
Download and complete the Virginia Catalyst Application for COVID-19 Grant Round
Submit the completed and signed application as a .pdf file to: suzeta@VirginiaCatalyst.org
- Support the acceleration of clinical testing by one or more Virginia companies of a therapeutic drug that treats life-threatening symptoms caused by COVID-19
- Encourage collaborative partnerships between investigators at one or more Virginia research universities and each grant recipient
- Increase Virginia’s national and global competitiveness in the life sciences by creating critical mass through collaborations between and among Virginia’s research universities and industry partners
- Create investment or jobs in Virginia
The Catalyst is now accepting applications for this special COVID-19 Grant Round.
Learn more about the Funding Criteria for COVID-19 Grant Round
Read the full press release
Download and complete the Virginia Catalyst Application for COVID-19 Grant Round
Submit the completed and signed application as a .pdf file to: suzeta@VirginiaCatalyst.org
Virginia Catalyst Awards $2.1 Million in Grant Round 11
RICHMOND, VA – October 26, 2020 – The Virginia Catalyst today announced that it has awarded $2.1 million in grants to three life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with significant matching funds from partner companies, were awarded as Round 11 of Virginia Catalyst’s ongoing mission to stimulate economic development by promoting collaborative projects that address large, unmet needs for improving human health, and that can create high-paying jobs in the Commonwealth.
Round 11 of grant funding project winners:
Project: Clinical Translation of a Male Contraceptive Procedure
Round 11 of grant funding project winners:
Project: Clinical Translation of a Male Contraceptive Procedure
- Company: Contraline, Inc. (Charlottesville, VA)
- University collaborators: University of Virginia and Virginia Commonwealth University
- Funding amount: $600,000
- Company: ISOThrive, Inc. (Manassas, VA)
- University collaborators: George Mason University, Eastern Virginia Medical School, and University of Virginia
- Funding amount: $800,000
- Company: Meru Biotechnologies (Richmond, VA)
- University collaborators: Virginia Commonwealth University and Old Dominion University
- Funding amount: $700,000
Special Webinar - How to Score High and Get Funding
On April 22nd the Virginia Catalyst and Virginia Bio co-hosted a special webinar that featured a panel of experts sharing what it takes to score highly and get funding.
Panel members:
Mike Grisham, President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc.
Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute
James Powers, Chairman and CEO, HemoShear Theapeutics, LLC
Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation
The recorded webinar can be viewed here
Click here to view the slides
Read the full press release here
Panel members:
Mike Grisham, President and CEO, Virginia Catalyst, Founder and CEO, GPB Scientific, Inc.
Mickey Kim, former Senior Vice President, Research and Commercialization, Inova Translational Medicine Institute
James Powers, Chairman and CEO, HemoShear Theapeutics, LLC
Thomas D. Roberts III, General Partner, Harbert Growth Partners, Harbert Management Corporation
The recorded webinar can be viewed here
Click here to view the slides
Read the full press release here
Our Strategic Initiatives - Actions and Results for Virginia
At the Virginia Catalyst we specialize in developing and leading strategic initiatives in areas were Virginia can be a national and global leader. We support these initiatives with grant funding for collaborative projects, investments creating research tools, and infrastructure that provide our research universities, healthcare systems and companies a competitive advantage over other regions in the country.
|
Our goal is to have the Commonwealth of Virginia be the very best in the nation at translational medicine and commercialization. We will achieve this by teaming up the biosciences industry with our world-class academic researchers and focusing efforts on solving large unmet medical needs. – Michael Grisham, CEO |
|
Grant Funding Program
Continuing powerful impact through our Grant Funding Program Grant funding for collaborations of universities and industry on commercialization projects Our competitive grant funding rounds, for collaborations of universities and industry on commercialization projects brought Virginia a 10-to-1 return on investment! |
About the Virginia Catalyst
We are a not-for-profit 501(c)(3) corporation created by the Virginia General Assembly and funded by the Commonwealth’s General Fund and seven Virginia public research universities: Eastern Virginia Medical School, George Mason University, Old Dominion University, University of Virginia, Virginia Commonwealth University, Virginia Tech and William & Mary.
Our Mission
Our mission is to advance economic development by creating competitive critical mass for Virginia life sciences through collaborations with our research universities and industry, to attract research and commercialization capital to Virginia and to catalyze the commercialization of Virginia’s innovations that meet large, unmet medical needs, improve human health and to create many more high-paying life science jobs in Virginia.
